Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Poll

More »
Oct 15, 2012

Biosimilars and Patient Safety

If one of your prescription drugs were switched to a biosimilar, how comfortable would you be with the switch?

Completely comfortable
 
  25.8%
Mostly comfortable
 
  32.8%
Indifferent
 
  8.6%
Mostly uncomfortable
 
  14.1%
Give me the real thing!
 
  18.8%

Suggest a Poll
More Polls » View Results »

Under the Affordable Care Act, Congress authorized the FDA to create a new pathway for the approval of copies of next-generation biologic drugs that are already approved and on the market. These copies, called biosimilars, are near-reproductions of a biologic drug, and if manufactured safely they can expand access to life-saving, life-enhancing medicines. However, a small difference in manufacturing process or in the cell line can alter the molecular structure between an original product and its biosimilar copies. Even slight variations could result in serious health implications for patients. So, how would you feel about replacing your drugs with biosimilars?

GEN Poll

More » Poll Results » Archive »

The Price of BRCA Testing

Is getting a genetic test worth the multi-thousand dollar price?

Suggest a Poll